<DOC>
	<DOCNO>NCT01557075</DOCNO>
	<brief_summary>The purpose study determine whether high dose statin therapy patient aspirin mono antiplatelet therapy receive drug-eluting stent ( DES ) previously free adverse cardiac event first 12 month could superior pravastatin therapy prevention late adverse cardiac cerebrovascular event additional 12 month . Study Design .</brief_summary>
	<brief_title>Aspirin Mono Therapy 12-months After Drug-eluting Stents Implantation</brief_title>
	<detailed_description>Objective : To determine whether high dose statin therapy patient aspirin mono antiplatelet therapy receive drug-eluting stent ( DES ) previously free adverse cardiac event first 12 month could superior pravastatin therapy prevention late adverse cardiac cerebrovascular event additional 12 month . Study Design - Prospective , randomize , multi-center study 1000 subject enrol . - Eligible subject randomize 1:1 ) atorvastatin 40 mg ( n=1000 ) vs. b ) pravastatin 20 mg/day ( n=1000 ) . All subject follow 1 year randomization . Additional long-term follow-up ( 2- 3-year ) precede next plan 1-year study period . - Subjects coronary artery diseases meet inclusion exclusion criterion include Clinical laboratory follow-up performed .</detailed_description>
	<mesh_term>Aspirin</mesh_term>
	<mesh_term>Atorvastatin Calcium</mesh_term>
	<mesh_term>Pravastatin</mesh_term>
	<mesh_term>Hydroxymethylglutaryl-CoA Reductase Inhibitors</mesh_term>
	<criteria>1 . Patients previously receive DES least 12 month ( ±2month ) ago 2 . Patients free death , MI , stroke , repeat revascularization , ST within first 12 month DES implantation 3 . Patients mono antiplatelet therapy aspirin 4 . Age 20 year old 5 . Patients sign informed consent 1 . History DES BMS implantation within 10 month 2 . Patients require continue dual antiplatelet therapy additional type antithrombotics antiplatelets cilostazol ticlopidine , etc besides aspirin DES implantation 3 . Patients could prescribe aspirin statin due contraindication severe side effect 4 . Pregnant woman woman potential childbearing 5 . Life expectancy ≤ 2 year</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2012</verification_date>
	<keyword>High dose statin</keyword>
</DOC>